220 related articles for article (PubMed ID: 22678079)
21. Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.
Tap WD; Eilber FC; Ginther C; Dry SM; Reese N; Barzan-Smith K; Chen HW; Wu H; Eilber FR; Slamon DJ; Anderson L
Genes Chromosomes Cancer; 2011 Feb; 50(2):95-112. PubMed ID: 21117066
[TBL] [Abstract][Full Text] [Related]
22. Clinical Application of Chromosome Microarray Analysis in the Diagnosis of Lipomatous Tumors.
Pei J; Flieder DB; Talarchek JN; Cooper HS; Patchefsky AS; Wei S
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):592-598. PubMed ID: 33734108
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of NCC-DDLPS3-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Fukushima S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 May; 34(3):1008-1018. PubMed ID: 33677797
[TBL] [Abstract][Full Text] [Related]
24. Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas.
Italiano A; Maire G; Sirvent N; Nuin PA; Keslair F; Foa C; Louis C; Aurias A; Pedeutour F
Cancer Lett; 2009 Jan; 273(2):323-30. PubMed ID: 18823700
[TBL] [Abstract][Full Text] [Related]
25. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
26. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
[TBL] [Abstract][Full Text] [Related]
27. Double minute chromosomes harboring MDM2 amplification in a pediatric atypical lipomatous tumor.
Dadone-Montaudié B; Burel-Vandenbos F; Soler C; Rosello O; Boyer C; Fabas T; Bianchini L; Pedeutour F
Genes Chromosomes Cancer; 2019 Sep; 58(9):673-679. PubMed ID: 30887579
[TBL] [Abstract][Full Text] [Related]
28. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.
Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP
Mod Pathol; 2024 Apr; 37(6):100494. PubMed ID: 38621503
[TBL] [Abstract][Full Text] [Related]
29. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
30. Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.
Dang TN; Tiongco RP; Brown LM; Taylor JL; Lyons JM; Lau FH; Floyd ZE
BMC Cancer; 2022 Mar; 22(1):300. PubMed ID: 35313831
[TBL] [Abstract][Full Text] [Related]
31. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
32. Gains of 13q are correlated with a poor prognosis in liposarcoma.
Schmidt H; Bartel F; Kappler M; Würl P; Lange H; Bache M; Holzhausen HJ; Taubert H
Mod Pathol; 2005 May; 18(5):638-44. PubMed ID: 15540119
[TBL] [Abstract][Full Text] [Related]
33. Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH.
Micci F; Teixeira MR; Bjerkehagen B; Heim S
Cytogenet Genome Res; 2002; 97(1-2):13-9. PubMed ID: 12438732
[TBL] [Abstract][Full Text] [Related]
34. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe.
Willmore-Payne C; Holden J; Turner KC; Proia A; Layfield LJ
Arch Pathol Lab Med; 2008 Jun; 132(6):952-7. PubMed ID: 18517278
[TBL] [Abstract][Full Text] [Related]
35. The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors.
Louis-Brennetot C; Coindre JM; Ferreira C; Pérot G; Terrier P; Aurias A
Genes Chromosomes Cancer; 2011 Nov; 50(11):896-907. PubMed ID: 21910158
[TBL] [Abstract][Full Text] [Related]
36. Well-differentiated and dedifferentiated liposarcomas.
Coindre JM; Pédeutour F; Aurias A
Virchows Arch; 2010 Feb; 456(2):167-79. PubMed ID: 19688222
[TBL] [Abstract][Full Text] [Related]
37. Formation of the 12q14-q15 amplicon precedes the development of a well-differentiated liposarcoma arising from a nonchondroid pulmonary hamartoma.
Trahan S; Erickson-Johnson MR; Rodriguez F; Aubry MC; Cheville JC; Myers JL; Oliveira AM
Am J Surg Pathol; 2006 Oct; 30(10):1326-9. PubMed ID: 17001166
[TBL] [Abstract][Full Text] [Related]
38. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL
Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
40. Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe.
Joos S; Scherthan H; Speicher MR; Schlegel J; Cremer T; Lichter P
Hum Genet; 1993 Feb; 90(6):584-9. PubMed ID: 8383093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
